DOCS
NEUTRALDr. Martens Announces Director/PDMR Shareholding
The footwear retailer has announced changes to director and PDMR shareholdings under the company's Share Incentive Plan.
Dr. Martens
75.25GBX
-0.86%
Market Cap
727.18M
Volume
567.83k
41% of avg
P/E Ratio
1341.12
EPS (TTM)
0.06
Beta
0.24
Day Range
75.00p - 78.35p
52 Week Range
43.02p75.25p100.87p
75.25p
Upcoming Events
DOCS
NEUTRALDr. Martens Director Increases Stake
The retailer has announced that one of its independent non-executive directors has purchased additional shares in the company.
DOCS
NEUTRALDr. Martens Director Increases Stake
The retailer has announced that one of its independent non-executive directors has purchased a block of shares in the company.
DOCS
NEUTRALDr. Martens Announces Major Shareholder Disclosure
The retailer has announced a change in major shareholder, with Artemis Investment Management LLP now holding over 11% of the company's shares.
DOCS
BADDr. Martens Reports Mixed H1 Results Amid Challenging Market Conditions
The footwear brand reported mixed H1 results, with revenue slightly down and continued losses. Despite some regional growth, it faces headwinds from tariffs and challenging market conditions.
DOCS
NEUTRALDr. Martens Directors Increase Shareholdings
The retailer has announced that its CEO and CFO have increased their shareholdings in the company through a share purchase scheme.
DOCS
NEUTRALDr. Martens Announces Change in Shareholding
The retailer has announced a change in shareholding, with Artemis Investment Management LLP's stake increasing above and then decreasing below the 11% notifiable threshold.
DOCS
NEUTRALDr. Martens Announces Change in Major Shareholder
The retailer has announced a change in its major shareholder, with Artemis Investment Management LLP increasing its stake in the company.
DOCS
NEUTRALDr. Martens Announces Director Shareholding Changes
The retailer has announced changes to the shareholdings of its Chief Executive Officer.
DOCS
NEUTRALDr. Martens Directors Increase Shareholdings
The retailer has announced that two of its directors have acquired additional shares in the company through an employee share scheme.